According to Novo Nordisk's financial report, in the first half of 2023, Ozmmpic (trade name for slimming indications of Semaglutide injection) achieved revenue of 41.741 billion Danish kroner (1 Danish kroner is approximately equivalent to 1.05 RMB, QCS editor refers to the exchange rate from February 29, 2024), and Wegovy (trade name for slimming indications of Semaglutide injection) achieved revenue of 12.081 billion Danish kroner, totaling 53.822 billion Danish kroner, equivalent to 7.6 billion US dollars, with an expected total of 20 billion US dollars for the whole year
There is growing evidence that excess generation of highly reactive free radicals, largely due to hyperglycemia causes OS, which further exacerbates the development of diabetes complications
Semaglutide, on the other hand, is used for weight loss and diabetes management
Conclusion In this tutorial, we have detailed the steps necessary to mix Semaglutide with bacteriostatic water, ensuring a safe and effective preparation for injection
However, tolerability, discontinuation rates, and comparative efficacy will be key watchpoints
